GNTA NASDAQ
Genenta Science S.p.A.
1W: +8.7%
1M: -23.8%
3M: -55.6%
YTD: -47.2%
1Y: -77.2%
3Y: -87.3%
$0.74
-0.06 (-7.30%)
Weekly Expected Move ±13.6%
$1
$1
$1
$1
$1
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$6M
+44.3% ▲
Capital Expenditures
$4K
+67.6% ▲
Free Cash Flow
-$6M
+44.3% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$890K
+103.4% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$6M | -$6M | -$8M | -$12M | -$9M |
| Depreciation & Amort. | $2K | $5K | $6K | $42K | $45K |
| Stock-Based Comp. | $460K | $497K | $723K | $740K | $847K |
| Change in Working Capital | -$921K | -$2M | $240K | -$418K | $2M |
| Other Non-Cash Items | $6K | $13K | $90K | $76K | $63K |
| Operating Cash Flow | -$6M | -$7M | -$7M | -$11M | -$6M |
| — Investing Activities — | |||||
| Capital Expenditures | -$21K | -$9K | -$27K | -$14K | -$4K |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | -$15M | -$16M |
| Investment Sales | $0 | $0 | $0 | $0 | $23M |
| Other Investing | $0 | $0 | $0 | -$305K | $0 |
| Investing Cash Flow | -$21K | -$9K | -$27K | -$15M | $7M |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $0 | $0 | $0 | $0 |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | -$111K | $543 | $0 | $0 | $271K |
| Financing Cash Flow | $1M | $29M | $0 | $531 | $271K |
| Net Change in Cash | -$5M | $22M | -$7M | -$26M | $890K |
| Cash End of Period | $15M | $37M | $30M | $4M | $5M |
| Free Cash Flow | -$6M | -$7M | -$7M | -$11M | -$6M |